mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
-0.061 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.063 |
0.7 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |